SEC Form 4 · accession 0001209191-17-018270
INTEGRA LIFESCIENCES HOLDINGS CORP · IART
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Raymond G. Murphy
Director
Period of report
Mar 2, 2017
Accepted (ET)
Mar 6, 2017 · 4:09 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000917520
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Mar 2, 2017 | M | 5,238 | $10.74 | A | 66,132 | D | |
| Common StockF2 | Mar 2, 2017 | S | 5,238 | $43.0065 | D | 60,894 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy)F4,F3 | $10.74 | Mar 2, 2017 | M | 5,238 | D | — | May 20, 2017 | Common Stock | 5,238 | 0 | D |
Explanation of responses
- F1On December 21, 2016, the common stock of Integra LifeSciences Holdings Corporation split two-for-one, resulting in the reporting person's ownership of one additional share of common stock for each share of common stock owned as of that date, as reflected in the totals listed on this Form 4.
- F2The price shown above represents the weighted average price of the shares sold. The range of sale prices was $42.84 to $43.09.
- F325% of the stock options vested every quarter from the grant date of 5/20/2009.
- F4This employee's stock option was previously reported as covering 7,829 shares of common stock at an exercise price of $21.48 per share. In accordance with the terms of the stock option plan, the exercise price of the option and number of shares subject to the option have been adjusted to reflect the two-for-one stock split that occurred on December 21, 2016.